Disclosed are compounds of Formula 1, including all stereoisomers, oxides, and salts thereof, wherein A, W, X, G, R, R, R, R, m and n are as defined in the disclosure. Also disclosed are pharmaceutical compositions containing the compounds of Formula 1 and methods for treating a disease or condition mediated by fatty acid amide hydrolase activity comprising applying a therapeutically effective amount of a compound or a composition of the invention.